Frankfurt - Delayed Quote EUR

Wellnex Life Limited (22W0.F)

Compare
0.4320 -0.0020 (-0.46%)
At close: December 23 at 8:15:59 AM GMT+1
Loading Chart for 22W0.F
DELL
  • Previous Close 0.4340
  • Open 0.4320
  • Bid 0.4320 x --
  • Ask 0.4560 x --
  • Day's Range 0.4320 - 0.4320
  • 52 Week Range 0.3250 - 0.8750
  • Volume 10,000
  • Avg. Volume 238
  • Market Cap (intraday) 12.96M
  • Beta (5Y Monthly) 0.77
  • PE Ratio (TTM) --
  • EPS (TTM) -0.4900
  • Earnings Date Mar 4, 2025 - Mar 10, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness solutions in Australia and internationally. The company offers medicinal cannabis under the Wellness Life brand; topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; sleep aid products under the Nighty Night brand; caffeine energy supplements under the Wakey Wakey brand; iron gummies under The Iron Company brand; teeth whitening products under the Mr Bright brand; over-the-counter medicines under the Pharmacy Own brand; and pain relief product under the Wagner Liquigesics brand. It also provides organic baby skincare, aromatherapy essential oils, and domestic cleaning products; and contract manufacturing services. In addition, the company licenses intellectual properties and trademarks of its products. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Port Melbourne, Australia.

wellnexlife.com.au

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: 22W0.F

View More

Performance Overview: 22W0.F

Trailing total returns as of 12/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

22W0.F
13.60%
S&P/ASX 200 [XJO]
8.30%

1-Year Return

22W0.F
21.45%
S&P/ASX 200 [XJO]
9.59%

3-Year Return

22W0.F
77.48%
S&P/ASX 200 [XJO]
10.79%

5-Year Return

22W0.F
96.40%
S&P/ASX 200 [XJO]
21.00%

Compare To: 22W0.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 22W0.F

View More

Valuation Measures

Annual
As of 12/23/2024
  • Market Cap

    13.30M

  • Enterprise Value

    19.15M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.72

  • Price/Book (mrq)

    3.57

  • Enterprise Value/Revenue

    1.89

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -81.12%

  • Return on Assets (ttm)

    -20.17%

  • Return on Equity (ttm)

    -412.95%

  • Revenue (ttm)

    16.94M

  • Net Income Avi to Common (ttm)

    -13.74M

  • Diluted EPS (ttm)

    -0.4900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    956k

  • Total Debt/Equity (mrq)

    176.02%

  • Levered Free Cash Flow (ttm)

    3.76M

Research Analysis: 22W0.F

View More

Company Insights: 22W0.F

Research Reports: 22W0.F

View More